DK1442124T3 - Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden - Google Patents
Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstandenInfo
- Publication number
- DK1442124T3 DK1442124T3 DK02783174T DK02783174T DK1442124T3 DK 1442124 T3 DK1442124 T3 DK 1442124T3 DK 02783174 T DK02783174 T DK 02783174T DK 02783174 T DK02783174 T DK 02783174T DK 1442124 T3 DK1442124 T3 DK 1442124T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide antigen
- polypeptide
- mimetic structure
- antigen forming
- hiv
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 101800001690 Transmembrane protein gp41 Proteins 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0112806A FR2830534B1 (fr) | 2001-10-05 | 2001-10-05 | Antigene polypeptidique formant une structure mimant l'etat intermediaire de gp41. |
| US34790901P | 2001-11-07 | 2001-11-07 | |
| PCT/FR2002/003188 WO2003042388A1 (fr) | 2001-10-05 | 2002-09-18 | ANTIGENE POLYPEPTIDIQUE FORMANT UNE STRUCTURE MIMANT L'ETAT INTERMEDIAIRE DE gp41 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1442124T3 true DK1442124T3 (da) | 2007-04-10 |
Family
ID=26213208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02783174T DK1442124T3 (da) | 2001-10-05 | 2002-09-18 | Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6821723B2 (da) |
| EP (1) | EP1442124B1 (da) |
| AT (1) | ATE348888T1 (da) |
| CA (1) | CA2462710C (da) |
| CY (1) | CY1106017T1 (da) |
| DE (1) | DE60216958T2 (da) |
| DK (1) | DK1442124T3 (da) |
| ES (1) | ES2275926T3 (da) |
| PT (1) | PT1442124E (da) |
| WO (1) | WO2003042388A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0422439D0 (en) * | 2004-10-08 | 2004-11-10 | European Molecular Biology Lab Embl | Inhibitors of infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2781676B1 (fr) * | 1998-07-31 | 2004-04-02 | Pasteur Merieux Serums Vacc | Trimere du produit d'expression du gene env de hiv |
| AU2604200A (en) * | 1999-01-08 | 2000-07-24 | Panacos Pharmaceuticals, Inc. | Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| DE60037450T2 (de) * | 1999-12-16 | 2008-12-04 | Whitehead Institute For Biomedical Research, Cambridge | Fünf-helix protein |
| AU2001243639A1 (en) * | 2000-03-17 | 2001-10-03 | Panacos Pharmaceuticals, Inc. | A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins |
-
2002
- 2002-09-18 CA CA2462710A patent/CA2462710C/en not_active Expired - Fee Related
- 2002-09-18 PT PT02783174T patent/PT1442124E/pt unknown
- 2002-09-18 EP EP02783174A patent/EP1442124B1/fr not_active Expired - Lifetime
- 2002-09-18 AT AT02783174T patent/ATE348888T1/de active
- 2002-09-18 ES ES02783174T patent/ES2275926T3/es not_active Expired - Lifetime
- 2002-09-18 WO PCT/FR2002/003188 patent/WO2003042388A1/fr active IP Right Grant
- 2002-09-18 DE DE60216958T patent/DE60216958T2/de not_active Expired - Lifetime
- 2002-09-18 DK DK02783174T patent/DK1442124T3/da active
- 2002-10-02 US US10/263,103 patent/US6821723B2/en not_active Expired - Fee Related
-
2007
- 2007-02-14 CY CY20071100196T patent/CY1106017T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1442124A1 (fr) | 2004-08-04 |
| US6821723B2 (en) | 2004-11-23 |
| ATE348888T1 (de) | 2007-01-15 |
| DE60216958D1 (de) | 2007-02-01 |
| ES2275926T3 (es) | 2007-06-16 |
| CA2462710C (en) | 2011-05-17 |
| CA2462710A1 (en) | 2003-05-22 |
| WO2003042388A1 (fr) | 2003-05-22 |
| DE60216958T2 (de) | 2007-10-04 |
| CY1106017T1 (el) | 2011-04-06 |
| US20030138445A1 (en) | 2003-07-24 |
| PT1442124E (pt) | 2007-02-28 |
| EP1442124B1 (fr) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE542829T1 (de) | Impfstoff | |
| FR2814958B1 (fr) | Composition vaccinale | |
| ID30497A (id) | Peptida hiv, antigen, komposisi vaksin, kit imunoasai dan metoda untuk mendeteksi antibodi yang diinduksi oleh hiv | |
| EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
| HUP0303134A3 (en) | Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv | |
| IL221708A0 (en) | Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response | |
| DK1362109T3 (da) | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale | |
| ES2194836T3 (es) | Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana. | |
| EA200700496A1 (ru) | Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита | |
| BR0312808A (pt) | Proteìna de fusão igg fc/hiv-gp120/c3d | |
| WO2006044410A3 (en) | A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines | |
| DE60222296D1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
| WO2003015702A3 (en) | Epitopes of human immunodeficiency virus-1 | |
| DK1442124T3 (da) | Polypeptidantigen, der danner en mimetisk struktur af gp41-mellemstanden | |
| DK1374895T3 (da) | Farmaceutisk sammensætning af F(AB) 2-fragmenter af antistoffer og fremgangsmåde til fremstilling heraf | |
| CY1105629T1 (el) | Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv | |
| DK0714307T3 (da) | Vaccinesammensætninger | |
| DE60333027D1 (de) | Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi | |
| WO2004053100A3 (en) | Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same | |
| DK1641488T3 (da) | Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin | |
| ATE303821T1 (de) | Neue vakzinformulierung aus dna-vakzine- inaktiviertem virus | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| MXPA03008083A (es) | Anticuerpo monoclonal especifico para epitopo de glicoproteina codificada por inmunodeficiencia felina inactivada. | |
| HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
| AU2001270226A1 (en) | Tolerance and chronic hepatitis c virus |